Dexchlorpheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 2 MG/ML / phenylephr... — RxCUI 1990881
RxNorm drug concept · Semantic clinical drug
RxCUI 1990881
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1990881
Official nameDexchlorpheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 2 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdexchlorpheniramine maleate 1 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG per 5 mL Oral Solution; dexchlorpheniramine maleate 1 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG in 5 mL Oral Solution
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Phenylephrine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It depends on the product. The injection raises low blood pressure during anesthesia and, for some products, septic shock. Eye drops dilate the pupil, nasal products relieve conges...
- Be careful. Over-the-counter phenylephrine should not be used with a prescription MAOI or within 2 weeks of stopping one. If you aren't sure whether your medicine is an MAOI, ask m...
- With the injection, the most common are nausea, vomiting and headache. Call for help right away if you have chest pain, a very slow heartbeat, or pain or skin changes around the IV...
- Stop and talk to a doctor if you get nervousness, dizziness or sleeplessness. Also stop if symptoms last more than 7 days or come with a fever. Don't use more than the label recomm...
🕸️ Concept Web — How Dexchlorpheniramine maleate 0.2 MG/ML / dextrome... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Dexchlorpheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 2 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution
RxCUI 1990881 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 7
The active substance itself — no strength, form, or brand attached yet.
-
Dexchlorpheniramine
22697IN -
Dextromethorphan
3289IN -
Phenylephrine
8163IN -
Dexchlorpheniramine / dextromethorphan / phenylephrine
827172MIN -
Dexchlorpheniramine maleate
54828PIN -
Dextromethorphan hydrobromide
102490PIN -
Phenylephrine hydrochloride
8164PIN
-
Dexchlorpheniramine
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Dexchlorpheniramine / dextromethorphan / phenylephrine Oral Solution
1990880SCDF -
Dexchlorpheniramine maleate / dextromethorphan hydrobromide / phenylephrine hydrochloride Oral Solution
2645650SCDFP -
Dexchlorpheniramine / dextromethorphan / phenylephrine Oral Liquid Product
1157774SCDG -
Dexchlorpheniramine / dextromethorphan / phenylephrine Oral Product
1157775SCDG -
Dexchlorpheniramine maleate / dextromethorphan hydrobromide / phenylephrine hydrochloride Oral Liquid Product
2661166SCDGP -
Dexchlorpheniramine maleate / dextromethorphan hydrobromide / phenylephrine hydrochloride Oral Product
2661353SCDGP -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Dexchlorpheniramine / dextromethorphan / phenylephrine Oral Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Dexchlorpheniramine maleate 0.2 MG/ML
996700SCDC -
Dextromethorphan hydrobromide 2 MG/ML
996519SCDC -
Phenylephrine hydrochloride 1 MG/ML
996578SCDC
-
Dexchlorpheniramine maleate 0.2 MG/ML
Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Dexchlorpheniramine maleate 0.2 MG/ML
SCDC · 996700 -
Dextromethorphan hydrobromide 2 MG/ML
SCDC · 996519 -
Phenylephrine hydrochloride 1 MG/ML
SCDC · 996578 -
Dexchlorpheniramine / dextromethorphan / phenylephrine Oral Solution
SCDF · 1990880 -
Dexchlorpheniramine maleate / dextromethorphan hydrobromide / phenylephrine hydrochloride Oral Solution
SCDFP · 2645650 -
Dexchlorpheniramine / dextromethorphan / phenylephrine Oral Liquid Product
SCDG · 1157774 -
Dexchlorpheniramine / dextromethorphan / phenylephrine Oral Product
SCDG · 1157775 -
Dexchlorpheniramine maleate / dextromethorphan hydrobromide / phenylephrine hydrochloride Oral Liquid Product
SCDGP · 2661166 -
Dexchlorpheniramine maleate / dextromethorphan hydrobromide / phenylephrine hydrochloride Oral Product
SCDGP · 2661353
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 1990881 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 69367-0334-16 | 480 mL in 1 BOTTLE, PLASTIC (69367-334-16) | WesTussin DM | Westminster Pharmaceuticals, LLC | 2021-07-29 |
Observed labelers:
Westminster Pharmaceuticals, LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.0411
Range $0.0411–$0.0411
· middle 50% $0.0411–$0.0411
· 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.